Richard J. Schwartz - Publications
Affiliations: | 1964-2009 | Electrical and Computer Engineering | Purdue University, West Lafayette, IN, United States |
Area:
solar cell energyWebsite:
https://engineering.purdue.edu/Engr/AboutUs/News/Publications/EngineeringImpact/2009_1/ECE_Issue/AnIlluminatingCareerYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Vij R, Wang M, Orlowski R, Stewart AK, Jagannath S, Kukreti V, Taylor J, Fuhrman D, Cruickshank S, Schwartz R, Kunkel L, Siegel D. Initial Results of PX-171-004, An Open-Label, Single-Arm, Phase II Study of Carfilzomib (CFZ) in Patients with Relapsed Myeloma (MM) Blood. 112: 865-865. DOI: 10.1182/Blood.V112.11.865.865 | 0.42 | |||
2008 | Jagannath S, Vij R, Stewart AK, Somlo G, Jakubowiak A, Reiman T, Trudel S, Taylor J, Fuhrman D, Cruickshank S, Schwartz R, Kunkel L, Siegel D. Initial Results of PX-171-003, An Open-Label, Single-Arm, Phase II Studyof Carfilzomib (CFZ) in Patients with Relapsed and Refractory Multiple Myeloma (MM) Blood. 112: 864-864. DOI: 10.1182/Blood.V112.11.864.864 | 0.419 | |||
2007 | Khoury HJ, Michallet M, Corm S, Roy L, Jones D, Hochhaus A, Kantarjian H, Benichou A, Schwartz R, Cortes J. Safety and Efficacy Study of Subcutaneous Homoharringtonine (SC HHT) in Imatinib (IM)-Resistant Chronic Myeloid Leukemia (CML) with the T315I Mutation - Initial Report of a Phase II Trial. Blood. 110: 1050-1050. DOI: 10.1182/Blood.V110.11.1050.1050 | 0.381 | |||
Show low-probability matches. |